Gritstone Bio Inc (GRTS)
0.81
-0.01
(-1.50%)
USD |
NASDAQ |
May 24, 11:32
Gritstone Bio Cash from Investing (TTM): 93.47M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 93.47M |
| December 31, 2023 | 102.34M |
| September 30, 2023 | 17.89M |
| June 30, 2023 | 2.688M |
| March 31, 2023 | 0.575M |
| December 31, 2022 | -12.96M |
| September 30, 2022 | -13.44M |
| June 30, 2022 | 24.65M |
| March 31, 2022 | -21.32M |
| December 31, 2021 | -118.55M |
| September 30, 2021 | -60.31M |
| Date | Value |
|---|---|
| June 30, 2021 | -85.74M |
| March 31, 2021 | -38.42M |
| December 31, 2020 | 65.95M |
| September 30, 2020 | 12.98M |
| June 30, 2020 | 31.23M |
| March 31, 2020 | 29.18M |
| December 31, 2019 | 15.84M |
| September 30, 2019 | -34.27M |
| June 30, 2019 | -53.26M |
| March 31, 2019 | -63.45M |
| December 31, 2018 | -59.10M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-118.55M
Minimum
Dec 2021
102.34M
Maximum
Dec 2023
-2.073M
Average
1.632M
Median
Cash from Investing (TTM) Benchmarks
| Precision BioSciences Inc | 6.524M |
| Humacyte Inc | 0.588M |
| Verastem Inc | -12.66M |
| BioVie Inc | 12.73M |
| Adial Pharmaceuticals Inc | -- |